Interpreting Clinical Trial Results with the DESCRibe Method: From Data to Decisions
On this page
Introduction
The purpose of a clinical trial is not just to generate numbers, but to provide meaningful, interpretable answers to therapeutic questions. Once data are collected and analyzed, the hardest—and most clinically important—task begins: interpreting what those numbers actually mean.
The DESCRibe method offers a structured, rigorous framework for interpreting the results of therapeutic studies. Whether you're a student of clinical epidemiology or a decision-maker at the bedside, this approach ensures you extract the true signal from the statistical noise.
The DESCRibe Method: An Overview
DESCRibe is a mnemonic encompassing six critical components of interpretation:
- Direction
- Effect size
- Statistical significance
- Clinical significance
- Reasonable biological plausibility
- inference (overall conclusion)
Each component acts as a lens through which to assess the results, ensuring that no key insight or pitfall is missed.
1. Direction: Which Way Did the Results Lean?
What it means:
Direction tells us the polarity of association—did the treatment reduce, increase, or have no effect on the outcome?
How to interpret:
- Look at the mean or median differences between groups.
- Identify whether the intervention arm performed better or worse.
- Note the "sign" of the effect (positive vs. negative).
Example:
Imagine a study assessing whether a breathing retraining app reduces daily asthma symptoms. The direction is favorable if the app group reports lower symptom scores compared to controls.
2. Effect Size: How Large Was the Impact?
What does it mean:
Effect size quantifies the magnitude of difference between treatment arms—how much better (or worse) the intervention was.
Common metrics:
- Mean difference for continuous outcomes (e.g., blood pressure)
- Risk difference or risk ratio for binary outcomes (e.g., mortality)
- Hazard ratio for time-to-event data (e.g., time to readmission)
Why it matters:
A statistically significant result can still be clinically meaningless if the effect size is trivial.
Example:
A new physical therapy protocol decreases length of hospital stay by 0.3 days. Direction = favorable, but effect size = small, possibly not practice-changing.
3. Statistical Significance: Is the Effect Real or Random?
What does it mean:
This step determines whether the observed effect is unlikely due to chance, based on probability thresholds.
Tools:
- P-values: Typically, a p < 0.05 indicates statistical significance.
- Confidence Intervals (CI): If the CI excludes the "no effect" value (e.g., 0 for difference or 1 for ratios), the result is considered statistically significant.
Watch out:
- Over-reliance on p-values ignores effect size and plausibility.
- Narrow CIs imply precision; wide CIs suggest imprecision.
Example:
In a drug trial, a reduction in HbA1c of 0.4% (95% CI: 0.3 to 0.5) with p < 0.001 is statistically significant and precise.
4. Clinical Significance: Does It Matter for Patients?
What it means:
Clinical significance assesses whether the result is important enough to influence patient care.
Considerations:
- Patient-centered outcomes
- Minimal Clinically Important Difference (MCID)
- Resource implications and burden of treatment
Example:
An antihypertensive reduces systolic BP by 2 mmHg (p < 0.001). Statistically significant—but unlikely to change guidelines without better outcomes like stroke prevention.
5. Reasonable Biological Plausibility: Does It Make Sense?
What it means:
Do the results align with existing physiologic, pathophysiologic, or pharmacologic understanding?
Red flags:
- Unexpected results without mechanistic explanation
- Effect contradicts prior strong evidence without justification
Example:
A high-dose vitamin C supplement shows a large reduction in sepsis mortality, but the effect is biologically implausible, and prior trials found no benefit. Interpretation must be cautious.
6. Inference: What Should We Conclude?
Pulling it all together:
After evaluating each domain, the final step is to draw a conclusion about the intervention’s efficacy, safety, and relevance.
- Does the evidence support adopting the intervention?
- Should it change practice, inform further research, or be disregarded?
Practical Application:
- Low risk of bias + consistent DESCRibe findings = high-confidence recommendation
- Mixed DESCRibe profile = cautious interpretation, call for replication
- Implausible or clinically irrelevant effects = dismiss despite significance
Example Walkthrough Using DESCRibe
Let’s apply DESCRibe to a fictional trial on a new sleep aid:
| Component | Assessment |
| Direction | Sleep latency decreased (positive effect) |
| Effect size | Average reduction of 15 minutes in time to sleep onset |
| Statistical significance | P = 0.01, 95% CI = –25 to –5 minutes |
| Clinical significance | May be relevant for insomnia patients; borderline for broader application |
| Biological plausibility | Melatonin-based mechanism supports the result |
| Inference | Potentially useful; consider patient preference and context for adoption |
Conclusion
The DESCRibe method is more than a checklist—it's a cognitive scaffold that trains clinicians and researchers to interpret trial results critically and comprehensively. It elevates interpretation from "What does the p-value say?" to "What does this mean for practice?"
🔑 Summary of DESCRibe
- Direction: Which way is the effect?
- Effect size: How much?
- Statistical significance: Is it real?
- Clinical significance: Is it meaningful?
- Reasonable biological plausibility: Does it make sense?
- inference: So what?